Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children

A. Drilon, T. W. Laetsch, S. Kummar, S. G. Dubois, U. N. Lassen, G. D. Demetri, M. Nathenson, R. C. Doebele, A. F. Farago, A. S. Pappo, B. Turpin, A. Dowlati, M. S. Brose, L. Mascarenhas, N. Federman, J. Berlin, W. S. El-Deiry, C. Baik, J. Deeken, V. BoniR. Nagasubramanian, M. Taylor, E. R. Rudzinski, F. Meric-Bernstam, D. P.S. Sohal, P. C. Ma, L. E. Raez, J. F. Hechtman, R. Benayed, M. Ladanyi, B. B. Tuch, K. Ebata, S. Cruickshank, N. C. Ku, M. C. Cox, D. S. Hawkins, D. S. Hong, D. M. Hyman

Research output: Contribution to journal › Article › peer-review

1920 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children'. Together they form a unique fingerprint.

Medicine & Life Sciences